Back to Results
First PageMeta Content



Visterra’s Monoclonal Antibody in Development for the Treatment of Influenza A, VIS410, Demonstrated Significant Antiviral Activity and Reduced Duration of Respiratory Symptoms in Phase 2a Challenge Study – Study Ach
Add to Reading List

Document Date: 2017-10-03 19:39:49


Open Document

File Size: 127,86 KB

Share Result on Facebook
UPDATE